Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease

Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease.

Cimzia (certolizumab pegol) is a tumor necrosis factor blocker... similar to Humira (adalimumab) and Remicade (infliximab).

Cimzia is "PEGylated" to extend its half-life. It can be given every 4 weeks...instead of every 2 weeks like Humira.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote